Medifast Inc Stock Filter Stocks by Fundamentals
MED Stock | USD 32.47 0.59 1.85% |
MEDIFAST INC fundamentals help investors to digest information that contributes to MEDIFAST INC's financial success or failures. It also enables traders to predict the movement of MEDIFAST Stock. The fundamental analysis module provides a way to measure MEDIFAST INC's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to MEDIFAST INC stock.
MEDIFAST | Shares Owned by Institutions |
MEDIFAST INC Institutional Holders
Institutional Holdings refers to the ownership stake in MEDIFAST INC that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of MEDIFAST INC's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing MEDIFAST INC's value.Shares | Bank Of New York Mellon Corp | 2023-12-31 | 201.1 K | Charles Schwab Investment Management Inc | 2023-12-31 | 186.2 K | Hotchkis & Wiley Capital Management Llc | 2023-12-31 | 167.3 K | American Century Companies Inc | 2023-12-31 | 139.9 K | Jacobs Levy Equity Management, Inc. | 2023-09-30 | 129.7 K | Northern Trust Corp | 2023-12-31 | 125.5 K | Aqr Capital Management Llc | 2023-12-31 | 110.4 K | Ubs Group Ag | 2023-12-31 | 92 K | Ameriprise Financial Inc | 2023-12-31 | 91.3 K | Blackrock Inc | 2023-12-31 | 1.8 M | Vanguard Group Inc | 2023-12-31 | 1.7 M |
MEDIFAST Fundamentals
Return On Equity | 0.56 | ||||
Return On Asset | 0.25 | ||||
Profit Margin | 0.09 % | ||||
Operating Margin | 0.05 % | ||||
Current Valuation | 222.05 M | ||||
Shares Outstanding | 10.9 M | ||||
Shares Owned By Insiders | 2.70 % | ||||
Shares Owned By Institutions | 97.40 % | ||||
Number Of Shares Shorted | 2.66 M | ||||
Price To Earning | 13.99 X | ||||
Price To Book | 1.70 X | ||||
Price To Sales | 0.32 X | ||||
Revenue | 1.07 B | ||||
Gross Profit | 1.14 B | ||||
EBITDA | 139.51 M | ||||
Net Income | 99.42 M | ||||
Cash And Equivalents | 87.69 M | ||||
Cash Per Share | 5.57 X | ||||
Total Debt | 22.01 M | ||||
Debt To Equity | 0.43 % | ||||
Current Ratio | 1.29 X | ||||
Book Value Per Share | 18.69 X | ||||
Cash Flow From Operations | 147.66 M | ||||
Short Ratio | 5.83 X | ||||
Earnings Per Share | 9.10 X | ||||
Price To Earnings To Growth | 1.95 X | ||||
Target Price | 37.5 | ||||
Number Of Employees | 634 | ||||
Beta | 1.15 | ||||
Market Capitalization | 353.78 M | ||||
Total Asset | 309.91 M | ||||
Retained Earnings | 174.65 M | ||||
Working Capital | 131.73 M | ||||
Current Asset | 88.07 M | ||||
Current Liabilities | 23.56 M | ||||
Annual Yield | 0.21 % | ||||
Five Year Return | 2.53 % | ||||
Net Asset | 309.91 M | ||||
Last Dividend Paid | 4.95 |
About MEDIFAST INC Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze MEDIFAST INC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MEDIFAST INC using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MEDIFAST INC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out MEDIFAST INC Piotroski F Score and MEDIFAST INC Altman Z Score analysis. For information on how to trade MEDIFAST Stock refer to our How to Trade MEDIFAST Stock guide.Note that the MEDIFAST INC information on this page should be used as a complementary analysis to other MEDIFAST INC's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Complementary Tools for MEDIFAST Stock analysis
When running MEDIFAST INC's price analysis, check to measure MEDIFAST INC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MEDIFAST INC is operating at the current time. Most of MEDIFAST INC's value examination focuses on studying past and present price action to predict the probability of MEDIFAST INC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MEDIFAST INC's price. Additionally, you may evaluate how the addition of MEDIFAST INC to your portfolios can decrease your overall portfolio volatility.
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
CEOs Directory Screen CEOs from public companies around the world | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data |
Is MEDIFAST INC's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MEDIFAST INC. If investors know MEDIFAST will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MEDIFAST INC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.77) | Dividend Share 4.95 | Earnings Share 9.1 | Revenue Per Share 98.498 | Quarterly Revenue Growth (0.43) |
The market value of MEDIFAST INC is measured differently than its book value, which is the value of MEDIFAST that is recorded on the company's balance sheet. Investors also form their own opinion of MEDIFAST INC's value that differs from its market value or its book value, called intrinsic value, which is MEDIFAST INC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MEDIFAST INC's market value can be influenced by many factors that don't directly affect MEDIFAST INC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MEDIFAST INC's value and its price as these two are different measures arrived at by different means. Investors typically determine if MEDIFAST INC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MEDIFAST INC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.